Journal of Cancer Metastasis and Treatment: Annual Report of 2017

Published on: 4 Feb 2018 Viewed: 2481

On January 25, 2018, the 2017 Annual Report Meeting of Journal of Cancer Metastasis and Treatment (JCMT) was held. All members from the Wditorial Office attended this conference, and Carrie Wang, the Managing Editor of the journal made the Annual Report of JCMT to all the attendees.

JCMT guarantees the highest quality, constructive peer-review process and aims to foster a rapid, convenient, unbiased, and comprehensive publishing environment. In 2017, JCMT published 41 articles, which were mainly Original Articles and Reviews. The majority of authors were from the United States, India, UK, Italy, and other 20 countries and regions. Among them, 4 articles were from Special Issue Circulating Tumor Cells: Diagnostics and Clinical Applications organized by Dr. Pravin D. Potdar, 6 from Special Issue Cancer Immunotherapy organized by Prof. Shuen-Kuei Liao, and 7 from Special Issue How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome? organized by Dr. Klaus Pors.

Figure 1: Geographical breakdown of articles in 2017

With the improvement of quality, JCMT is increasingly known by experts and scholars across the world in the field of cancer metastasis and treatment. By December 26, 2017, 41 published articles have been read 34,250 times and downloaded 3,389 times in total. Among them, five articles received extensive attentions, especially one review article written by Dr. Stanley J. Oiseth, entitled Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead, which was published on October 31, 2017, has been viewed 548 times and downloaded 1,099 times (by February 1, 2018). Besides, compared to 2016, the monthly page view of 2017 has significantly increased, reaching a peak value of 11,450 (November 2017). At the same time, JCMT has expanded its readership to 173 regions worldwide, led by the United States, India, UK, China, and Canada.



Corresponding Author


Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead

Dr. Stanley J. Oiseth

Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target

Dr. Silvana Morello

DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progressionDr. Zhao-Hui WuReview
4A versatile method for enumeration and characterization of circulating tumor cells from patients with breast cancerDr. Ujjwala M. WarawdekarOriginal Article
Real-time quantitative PCR array to study drug-induced changes of gene expression in tumor cell linesDr. Mirco FanelliOriginal Article

Table 1: Top five popular articles in 2017

Figure2: Monthly page views of 2016 and 2017

Figure3: Readership in 2017

With continuous improvements in 2017, JCMT has attracted more experts from across the globe to contribute to the journal. Scholars with great academic influence are enthusiastic in organizing Special Issues. Until now, there are 6 ongoing Special Issues. Moreover, JCMT has expanded its cooperation with international institutions and  promoted its articles through many platforms such as Scholar one and Trend MD. At present, we are in cooperation with 19 international conferences. On Apr. 1-4, 2017, our Editors attended the 110th AACR Annual Meeting to finalize the scope of Special Issue with our EBM Prof. Chun Hei Antonio Cheung and Prof. Guofeng Xie.

Topic: Reviews of Gastric Cancer Metastasis and Treatment
Guest Editor: Prof. Masayuki Watanabe, MD, PhD
Topic: Cancer Pharmacogenomics 
Guest Editor: Prof. Godefridus J. Peters, PhD
Topic: Autophagy and Cancer-current biology and drug development
Guest Editor: Prof. Chun Hei Antonio Cheung, PhD
Topic: Colorectal Cancer Progression and Treatment 
Guest Editor: Prof. Guofeng Xie, MD, PhD
Topic: Hyponatremia and Cancer 
Guest Editor: Dr. Rossana Berardi, MD
Topic: Intra-Tumour Genetic Heterogeneity
Guest Editors: Dr. Luciano G. Martelotto, PhD; Prof. Yi-Hong Zhou, PhD

Table 2: Ongoing Special Issues

In order to improve the reader/author experience and achieve high efficiency in academic publishing, the editorial team has carried out overhauls in various aspects. In July 2017, the website underwent an optimization and the Editorial Board was reorganized. Soon afterwards, a new editorial team of 57 high achievers with remarkable influence both home and abroad was formed after careful evaluation. In December, the typesetting of articles was optimized.

We appreciate the dedicated efforts of our Editorial Board led by Prof. Lucio Miele, and every author, reviewer, and reader’s support. In 2018, JCMT will continue to adhere to strict peer review standards and other standards recommended by international publishing associations such as COPE for a high-quality journal with global influence.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: